15040856

Source:http://linkedlifedata.com/resource/pubmed/id/15040856

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003250, umls-concept:C0376358, umls-concept:C1328025, umls-concept:C1704419
pubmed:issue	3
pubmed:dateCreated	2004-3-25
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101155459
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1540-0352
pubmed:author	pubmed-author:DeGrendeleHeatherH
pubmed:issnType	Print
pubmed:volume	2
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	143-5
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:15040856-Androgen Antagonists, pubmed-meshheading:15040856-Antibodies, Monoclonal, pubmed-meshheading:15040856-Breast Neoplasms, pubmed-meshheading:15040856-Clinical Trials, Phase I as Topic, pubmed-meshheading:15040856-Female, pubmed-meshheading:15040856-Humans, pubmed-meshheading:15040856-Male, pubmed-meshheading:15040856-Middle Aged, pubmed-meshheading:15040856-Prostatic Neoplasms, pubmed-meshheading:15040856-Receptor, erbB-2, pubmed-meshheading:15040856-Treatment Outcome
pubmed:year	2003
pubmed:articleTitle	The anti-HER2 monoclonal antibody pertuzumab may be effective in androgen-independent prostate cancer.
pubmed:publicationType	Journal Article